[company_age]13.0[/company_age][employees]2-10 employees[/employees][funding]Series B[/funding][description]Hemics is a medical device company specializing in the field of Rheumatoid Arthritis (RA). Their mission is to improve the quality of life for RA patients by developing imaging devices that assist rheumatologists in monitoring and treating the disease. Hemics' technology is based on patented optical inflammation detection, a non-invasive, rapid, and operator-independent method that aids rheumatologists in objectively assessing inflammation, a crucial factor in RA treatment. Founded as a spin-off from Royal Philips Electronics, where the inflammation detection technology was invented, Hemics leverages its expertise to provide innovative solutions for RA management. Hemics' unique technology sets it apart from other companies in the RA treatment field, offering a more objective and efficient way to assess inflammation, leading to better treatment outcomes for patients.[/description][ps]Optical inflammation detection devices for Rheumatoid Arthritis monitoring.[/ps]